Art
J-GLOBAL ID:201802232543680363   Reference number:18A1707190

Translational Research in Immuno-Oncology-Comprehensive Analysis of Phenotypes and Functions of Various Immune Cells Using the Colorectal Cancer Surgical Sample

免疫腫瘍学(Immuno-Oncology)の夜明け Immuno-Oncologyにおけるトランスレーショナルリサーチ-大腸癌手術検体の網羅的解析による各種免疫細胞の形質・機能の解析-
Author (4):
Material:
Volume: 45  Issue:Page: 1238-1241  Publication year: Sep. 15, 2018 
JST Material Number: Z0938A  ISSN: 0385-0684  Document type: Article
Article type: 文献レビュー  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1707190&from=J-GLOBAL&jstjournalNo=Z0938A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Immunotherapy for tumors  ,  Tumors(=neoplasms)of digestive system 
Reference (12):
  • Torre LA, Bray F, Siegel RL, et al: Global cancer statistics, 2012. CA Cancer J Clin 65 (2): 87-108, 2015.
  • Larkin J, Hodi FS and Wolchok JD: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373 (13): 1270-1271, 2015.
  • Wolchok JD, Kluger H, Callahan MK, et al: Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med 369 (2): 122-133, 2013.
  • Le DT, Uram JN, Wang H, et al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372 (26): 2509-2520, 2015.
  • Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4): 252- 264, 2012.
more...

Return to Previous Page